Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Feb 12, 2026

Endonovo Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
-00.090.010.020.38
Cash & Short-Term Investments
-00.090.010.020.38
Cash Growth
--99.89%540.36%-28.97%-95.02%320.47%
Receivables
--000.020
Prepaid Expenses
0.040.020.010.030.02-
Total Current Assets
0.040.020.090.050.060.38
Property, Plant & Equipment
---00.010.01
Other Intangible Assets
0.781.271.912.563.213.85
Total Assets
0.821.282.012.613.274.24
Accounts Payable
0.930.880.660.70.60.16
Accrued Expenses
9.287.996.425.293.753.03
Short-Term Debt
0.10.110.130.140.170.27
Current Portion of Long-Term Debt
6.957.047.066.498.517.59
Other Current Liabilities
6.4417.363.444.210.64.43
Total Current Liabilities
23.733.3817.716.8323.6215.48
Other Long-Term Liabilities
0.080.080.080.160.160.16
Total Liabilities
23.7833.4617.7816.9823.7815.63
Common Stock
0.030.020.01000
Additional Paid-In Capital
43.6442.9240.6638.9632.4324.23
Retained Earnings
-66.63-75.12-56.44-53.34-52.93-35.62
Comprehensive Income & Other
-0-0-0-0-0-0
Total Common Equity
-22.96-32.18-15.77-14.37-20.5-11.39
Shareholders' Equity
-22.96-32.18-15.77-14.37-20.5-11.39
Total Liabilities & Equity
0.821.282.012.613.274.24
Total Debt
7.067.157.186.638.687.86
Net Cash (Debt)
-7.06-7.15-7.1-6.62-8.66-7.48
Net Cash Per Share
-0.03-0.05-0.12-0.54-12.41-20.65
Filing Date Shares Outstanding
318.75270.29149.5353.588.810.53
Total Common Shares Outstanding
318.75213.2374.524.541.190.43
Working Capital
-23.66-33.37-17.61-16.78-23.56-15.1
Book Value Per Share
-0.07-0.15-0.21-0.59-17.24-26.43
Tangible Book Value
-23.74-33.45-17.69-16.93-23.71-15.24
Tangible Book Value Per Share
-0.07-0.16-0.24-0.69-19.94-35.37
Machinery
---0.090.090.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.